Accounts Payable and Related Party (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
May 31, 2025 |
Feb. 26, 2025 |
|
| Issuance of prefunded warrant to settle vendor payable | $ 847,000 | $ 810,000 | |||||
| Issuance of pre-funded warrants | 24,390 | ||||||
| Exercise price | $ 2.46 | $ 2.8375 | |||||
| Cytovance Biologics Inc [Member] | |||||||
| Issuance of prefunded warrant to settle vendor payable, shares | 127,597 | ||||||
| Issuance of pre-funded warrants | 326,251 | 326,251 | 326,251 | ||||
| Exercise price | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||
| Payments in pre-funded warrants, at fair value | $ 847,000 | $ 847,000 | |||||
| Legal Services Firm [Member] | |||||||
| Prior year unpaid fees | $ 1,000,000 | ||||||
| Common Stock [Member] | |||||||
| Issuance of prefunded warrant to settle vendor payable, shares | 127,597 | 127,597 | |||||
| Issuance of prefunded warrant to settle vendor payable | |||||||
| Issuance of pre-funded warrants | 200,000 | 200,000 | |||||